Treatment Of Multiple Sclerosis
Multiple Sclerosis, or Treatment Of Multiple Sclerosis, is among the most common chronic inflammatory diseases of the central nervous system, affecting an estimated 2 million people worldwide. Symptoms of multiple sclerosis can include extreme fatigue, lack of coordination, numbness or tingling, bladder problems, cognitive impairment, tremors, mood changes, and weakness, among others, and can vary greatly from person to person.
Last year, research led by two Canadian doctors from Ottawa, Ontario, and published in The Lancet medical journal, revealed that a high-risk therapy may be able to stop the disease from progressing further.“This is the first Treatment Of Multiple Sclerosis to produce this level of disease control or neurological recovery” from multiple sclerosis, the journal said in a news release, but researchers also admit the procedure may be too risky to offer multiple sclerosis sufferers, as one out of the 24 patients involved in the clinical trial died from liver failure.
The Results Are Impressive: Despite this fact, the results are impressive. In the journal’s accompanying editorial, a German doctor marvelled at the treatment’s efficacy, noting that it’s the “first trial ever that showed complete suppression of any inflammatory disease actively in every single patient for a prolonged period.”This editorial also says that, for the time being, the Treatment Of Multiple Sclerosis should be restricted to specialized centres, warning that “all efforts must be taken to avoid stem cell tourism.
Stem cell tourism is something that has been happening at clinics worldwide, who claim that they can treat and even cure diseases like muscular dystrophy, Alzheimer’s, Parkinson’s, spinal cord injuries, and so on, without any solid research having been done to prove these claims, and at a great cost to the patient.
What Did The Study Involve?
The clinical trial, which was led by Dr. Mark Freedman and Dr. Harold Atkins from the Ottawa Hospital, involved 24 patients over a 13-year period.The patients underwent an intensive combination of chemotherapy and stem cell transplants in a procedure known as immunoablation and autologous hematopoietic stem cell transplantation.First, doctors harvested stem cells from the patients’ bone marrow, which they then purified and froze.
What One of the Patients Has to Say: Jennifer Molson remembers doctors saying, “We kill you and then we rescue you” before commencing her high-stakes procedure back in 2002.Prior to this Treatment Of Multiple Sclerosis , the 41-year-old Ottawa woman was in a wheelchair. “I had no feeling from my chest down. I could barely cut my food,” Molson said. Now, she walks, runs, and even works full time.She had been diagnosed with multiple sclerosis when she was 21 and within only five years needed full-time care.